Therma Bright Inc. Stock

Equities

THRM

CA8834261080

Advanced Medical Equipment & Technology

Market Closed - Toronto S.E. 01:25:04 2024-04-24 pm EDT 5-day change 1st Jan Change
0.01 CAD 0.00% Intraday chart for Therma Bright Inc. 0.00% -60.00%
Sales 2022 139K 102K Sales 2023 23.9K 17.47K Capitalization 10.3M 7.53M
Net income 2022 -5M -3.66M Net income 2023 -3M -2.19M EV / Sales 2022 236 x
Net cash position 2022 2.97M 2.17M Net cash position 2023 91.85K 67.15K EV / Sales 2023 427 x
P/E ratio 2022
-5.83 x
P/E ratio 2023
-2.58 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 95.1%
More Fundamentals * Assessed data
Dynamic Chart
Therma Bright Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024 CI
Therma Bright Inc. Reports Earnings Results for the First Quarter Ended October 31, 2023 CI
Therma Bright Inc. Reports Earnings Results for the Full Year Ended July 31, 2023 CI
Ontario Securities Commission Issues Cease Trade Order Against Therma Bright Inc CI
Therma Bright Prepares Fda 513(G) Review Therma Bright Prepares FDA 513(G) Review Analyzer CI
Therma Bright Inc. Announces Venowave Pilot Tests with Existing and New Distribution Partners in the United States CI
Therma Bright Inc. Announces Chief Financial Officer Changes CI
Therma Bright Inc Signs Hero Lifecare to A U.S. Distribution Partner for Marketing and Selling the Venowave Device CI
Therma Bright Inc. Submits Updated FDA 510K Application Requesting Correction of Venowave Device's Intended Use, Labeling, and Description CI
Therma Bright Inc. Provides Update on Venowave for the United States and Texas Region CI
Therma Bright Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023 CI
Therma Bright Inc. and Inretio Inc. Announces Successful Completion of Good Laboratory Practice Study for Its Breakthrough Preva™? Mechanical Thrombectomy Device CI
Therma Bright Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023 CI
Therma Bright Inc. Provides an Update on Its Partnership with Inretio Inc CI
Therma Bright Inc. Reports Earnings Results for the First Quarter Ended October 31, 2022 CI
More news
Current month-50.00%
1 month-33.33%
3 months-60.00%
6 months-71.43%
Current year-60.00%
More quotes
1 week
0.01
Extreme 0.01
0.02
1 month
0.01
Extreme 0.01
0.02
Current year
0.01
Extreme 0.01
0.03
1 year
0.01
Extreme 0.01
0.08
3 years
0.01
Extreme 0.01
0.54
5 years
0.00
Extreme 0
1.05
10 years
0.00
Extreme 0
1.05
More quotes
Managers TitleAgeSince
Chief Executive Officer 53 09-09-14
Director of Finance/CFO 78 16-05-17
Members of the board TitleAgeSince
Director/Board Member 76 18-01-16
Director of Finance/CFO 78 16-05-17
Chief Executive Officer 53 09-09-14
More insiders
Date Price Change Volume
24-04-24 0.01 0.00% 100,000
24-04-23 0.01 0.00% 60,100
24-04-22 0.01 0.00% 230,804
24-04-19 0.01 0.00% 894,017
24-04-18 0.01 0.00% 410,818

Delayed Quote Toronto S.E., April 24, 2024 at 01:25 pm EDT

More quotes
Therma Bright Inc. is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. The Venowave is a medical compression pump that is lightweight, compact, battery operated, designed to treat and alleviate the symptoms associated with poor circulation.
More about the company